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Summary: A sensitive and selective analytical technique is described for the 
determination of N-acetylaspartic acid in body fluids using stable isotope 
dilution in combination with positive chemical ionization mass spectrometry 
with selected ion monitoring. 
Control mean and ranges have been established: in urine 19.5 and 6.6- 
35.4#mol/mmol creat.; in plasma 0.44 and 0.17-0.81 #mol/L; in cerebrospinal 
fluid 1.51 and 0.25 2.83 #mol/L; and inamniotic fluid 1.27 and 0.30-2.55 #mol/L. 
In a patient with Canavan disease, N-acetylaspartic a id concentration was 
elevated 80-fold in urine and 20-fold in plasma compared to the control means. 
A subsequent pregnancy of the mother was monitored and the N-acetylaspartic 
acid concentration i the amniotic fluid was within the control range and a 
healthy child was born. 
INTRODUCTION 
Increased N-acetylaspartic a id (NAA) levels in urine, blood and cerebrospinal fluid 
(CSF) have been reported by Kvittingen et al. (1986) in a patient with cerebellar 
atrophy and by Hagenfeldt et al. (1987) in a patient with leukodystrophy. The 
excessive NAA excretion was probably caused by the deficiency of aspartoacylase 
(EC 3.5.1.15) as was demonstrated by Hagenfeldt et al. (1987) in their patient's 
fibroblasts. Subsequently Matalon et al. (1988) and Divry et al. (1989) linked N- 
acetylaspartic aciduria andaspartoacylase d ficiency with Canavan disease (Canavan, 
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1931) and this finding has ince been confirmed in at least 25 patients (Echenne t 
at., 1989; Elpeleg et al., 1989; Matalon et al., 1989; Ozand et al., 1990). 
Canavan disease (McKusick 27190) is a form of leukodystrophy inherited as an 
autosomal recessive disease (Buchanan and Davis, 1965; Van Bogaert and Bertrand, 
1967). The neurological symptoms usually appear in the first few months of life and 
are due to demyelinization a d leukodystrophy with associated megalencephalopathy, 
blindness and spasticity. Until recently the definitive diagnosis of Canavan disease 
required the demonstration f spongy degeneration f white matter in a biopsy or 
necropsy. The recent finding of N-acetylaspartic aciduria in patients with Canavan 
disease suggests that measurement of urinary NAA provides an easier diagnosis. 
As the course of this disease is devastating and treatment is not available, prenatal 
diagnosis is in demand. For several organic acidurias quantitation of specific 
metabolites in amniotic fluid is a reliable and fast method for prenatal diagnosis 
(Sweetman, 1984; Jakobs et al. 1990). We therefore developed a sensitive and accurate 
stable isotope dilution method for the quantitation ofNAA in amniotic fluid. Using 
this method we have established normal ranges for the concentrations of this 
compound in CSF, plasma, urine and amniotic fluid, which were hitherto not all 
available. 
A patient with Canavan disease was diagnosed as having N-acetylaspartic aciduria 
and in addition prenatal investigations were performed in a subsequent pregnancy. 
CASE REPORT 
In the affected family there is no evidence for consanguinity. However, the ancestors 
of the parents are from a very small village, so that it is necessary to calculate with 
the endogamy. In the three-generation genealogy there are no degenerative diseases. 
The index case, a girl, was born after an uncomplicated pregnancy and delivery. 
Birthweight was 2600 g and length 47 cm. She was normal until the age of 2 months 
when frequent tonic-clonic seizures up to four times a day were observed. The seizures 
were unresponsive toantiepileptic drug treatment. From the age of 3 months the girt 
showed an inversion of her sleep rhythm: she slept during daytime. Impaired 
psychomotor development became obvious from the age of 4 months. At that time 
muscle hypertonia was present; the upper extremities were in a flexed position and 
the lower extremities were in extension. She showed opisthotonus from the age of 9 
months. Choreoathethosis was not observed. The girl became severely disabled, 
deteriorating toa vegative state by the age of 2 years. Severe failure to thrive became 
obvious. The girl is still alive at 5 years of age. 
Ophthalmological examination revealed optic atrophy without retinal abnormali- 
ties and preserved pupil reflexes. A complete hearing loss has not been proved by 
electrophysiological tests. 
Electroencephalography recording showed only abnormal background activity 
with high beta activity. 
Skull X-ray showed macrocephaly. ACT  scan of the brain at 6 months of age 
revealed iffuse white matter hypodensity in both hemispheres as well as in the 
cerebellum, associated with an increased subarachnoidal space. A cerebral cortex 
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biopsy was performed at the age of 9 months and showed a marked vacuolization 
in the subcortical layer of the U-fibres producing a spongy appearance by light 
microscopy. There was a microspongiosis of the neuroepithelium and clear vacuoli- 
zation of the perivascular and of the perineuronal g ia within the grey mass of the 
middle layer of the cerebral cortex. 
The spongiosis originates from the hydrophobic degeneration of the increased 
quantity ofneuroglia with oxyphilic plasmatic spots characteristic ofCanavan disease. 
Ultrastructural studies revealed typical increase of dense megaconial mitochondria. 
Except for a hypochromic anaemia, no abnormalities were found on routine 
haematological nd biochemical testing. CSF analysis howed normal g ucose and 
cell count, but a constantly increased protein level (780mg/L; prealbumin 3.4%, 
albumin 70.1%, c~t 1.4%, ~2 4.2%,/3 10.5% and ~ 10.5%). 
Urine organic acids revealed N-acetylaspartic a iduria at the age of 5 years (see 
results). 
During the third pregnancy, prenatal investigation was performed in amniotic fluid 
and in cultured amniotic fluid cells. The biochemical examinations provided no 
evidence for an affected fetus. After delivery, the child (girl) demonstrated an 
uncomplicated neurological development during her first year of life and no other 
clinical signs of the disease are apparent. 
MATERIALS AND METHODS 
Materials: N-Acetylaspartic acid was purchased from Sigma Chemical Company, 
St. Louis MO, USA. [D3]-N-acetylaspartic acid was synthesized as described below. 
All other chemicals were of analytical grade and used without prior treatment. 
Synthesis of [D3]-N-acetylaspartie acid." To an ice-cooled solution of L-aspartic 
acid (0.13 g, 1 mmol) and sodium hydroxide (0.10 g, 2.5 retool) in water (600 ml) I-D6]- 
acetic anhydride (125 ml, 1.2 mmol, 99 atom% D, Janssen Chimica, Beerse, Belgium) 
was added, and the solution was shaken for 1 hour with cooling. The reaction mixture 
was acidified with HC1 to pH 1 and dried in a stream of nitrogen. The residue was 
extracted with acetone (20 ml), and the dried extract was washed with diethylether 
to yield [acetyl-D3]-N-acetylaspartic cid(0.15 g, 98 atom%) as a gum. The product 
was obtained in a crystalline form by crystallization from ethanot-diethyl ether. 
Sample collection: Control urine, plasma and CSF samples were obtained from 
healthy persons (age 1 week-14 years) who did not have any symptoms of hepatic 
or neurological disease. Control amniotic fluid samples were obtained in the 16-18th 
week of pregnancies in which the amniocentesis was performed because of advanced 
maternal age. 
Samples were stored at -20°C prior to the analysis. There has been no effect of 
sample storage observed uring the 2 years of this study. 
Sample preparation: An aqueous olution of [D3]-N-acetylaspartic acid was added 
as internal standard to 1.00 ml of a biological sample (25 nmol/#mol creat, for urine; 
5 nmol/ml for amniotic fluid, and 3 nmol/ml for plasma and CSF). This was also 
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added to an aqueous tandard, to obtain a calibration curve in the range from 5 to 
100 nmol for urine, 5 to 20 nmol for amniotic fluid, and 0.5 to 5 nmol for plasma nd 
CSF. The sample was acidified with 30/d HCI (6 tool/L) to pH < 2 and saturated 
with sodium chloride. Thereafter the sample was extracted four times with 2ml of 
an ethylacetate-2-propanol mixture (v/v 10: 1). The collected organic fractions were 
dried by anhydrous sodium sulphate and subsequently evaporated todryness at 40°C 
under a gentle stream of nitrogen. The residue was trimethylsilylated with a 50#1 
MSTFA/pyridine mixture (1 : 1). An aliquot of 1 #1 of this mixture was analysed by 
gas chromatography-mass spectrometry. 
Gas chromatography-mass spectrometry (GC-MS): GC-MS analysis of N-acetyl- 
aspartic acid-diTMS was performed on a Kratos MS-80 mass spectrometer (Kratos 
Ltd, Manchester, UK). The chromatographic separation was achieved on a CPSil- 
19-CB capillary fused silica column; 25 m x 0.32 mm with df = 0.48 #m (Chrompack 
Int., Middelburg, The Netherlands) which was directly inserted into the source of the 
mass spectrometer. Helium was used as carrier gas with a linear flow of 20 cm/s. A 
cold on-column injector was used. The oven temperature was kept at 120°C for 1 min 
and then raised to 250°C at a rate of 30°C/min. The interface and source temperatures 
were kept at 250°C. Mass fragmentography was achieved with positive chemical 
ionization with ammonia s reagent gas at a source pressure of 2 x 10 -4 torr. The 
filament emission current was 1.5mA and the electron energy was set at 40eV. 
The ions m/z 320.19 (base peak protonated pseudomolecular ion (M + 1) for 
N-acetylaspartic a id-diTMS) and m/z 323.21 (base peak (M + 1) for [D3]-N- 
acetylaspartic a id-diTMS) were monitored with a 50ms dwell time in the selected 
ion monitoring (SIM) mode at a resolution of 1000 (10% valley). The areas of the 
mass fragmentographic peaks were calculated by means of an operator-controlled 
data system. Mass spectra of authentic standards were obtained by scanning over 
the mass range of m/z 50-600 with a 3-s scan time. 
Enzyme analysis." Confluent cultures of skin fibroblasts and amniotic fluid cells were 
grown according to routine procedures and were harvested by trypsinization 7 days 
after the previous ubculture. Cells were washed in saline, homogenized by sonification 
in 3% Triton X-100 in water and centrifuged for 10 min at 10 000g. Aspartoacylase 
activity was assayed in the supernatant as described by Matalon et al. (1988). 
RESULTS 
Gas chromatography-mass spectrometry: Electron impact (EI) ionization of the di- 
TMS derivatives of NAA gave considerable fragmentation a d hence a rather low 
intensity of the molecular ion, and even the ion at m/z of M - 15 due to loss of a 
methyl group was only 7.6% of the base peak at m/z = 73. 
Chemical ionization (CI) with ammonia gave much less fragmentation a d the 
base peak in the spectra of NAA-diTMS and [D3]-NAA-diTMS were the protonated 
pseudomolecular ions (M + 1) (Figure la and lb). Therefore the protonated pseudo- 
molecular ions were determined in the SIM mode at m/z 320 for NAA-diTMS and 
m/z 323 for [D3]-NAA-diTMS. 
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Figure 1 (a) Ammonia chemical ionization mass spectrum of the di-TMS derivative of N- 
acetylaspartic a id. (b) Ammonia chemical ionization mass spectrum of the di-TMS derivative 
of [D3]-N-acetylaspartic acid. 
The actual imit of detection was 0.2 #mol/L for EI ionization, whereas we obtained 
0.02 #mol/L by using CI ionization. 
Quantitative data: The standard calibration curve yielded straight lines that went 
through the origin. Linear regression analysis was used to calculate the concentration 
of NAA in the biological samples. Table 1 shows the concentrations of NAA in CSF, 
plasma and urine of control individuals (age 1 week-14 years), the index case with 
N-acetylaspartic aciduria and her healthy sibling, together with the results of the 
aspartoacylase assays. There was no age dependency of the control NAA concentra- 
J. Inher, Metab, Dis. 14 (1991) 
658 Jakobs et al. 
Table 1 Concentrations of N-acetylaspartic acid in various body fluids and the aspartoacylase 
activity in cultured fibroblasts of the index case, the healthy newborn and controls 
N-Acetylaspartic acid AspartoacyIase in
Urine Plasma CSF fibroblasts 
(#mol/mmol creat.) (/~mol/L) (#mol/L) (nmol-i h- 1 (rag protein)- 1) 
Index case 1491 9.32 n.d. 0.0 
Newborn child 10.0 n.~. n.d. n.d. 
Controls (n = 25) (n = 25) (n = 14) (n = 23) 
Mean 19.5 _+ 10.3 0.44 _+ 0.20 1.51 _+ 0.89 16.8 + 7.9 
Range 6.6-35.4 0.17-0.84 0.25-2.83 6.0-29.4 
n.d. = not determined 
tions in urine and plasma. NAA levels in urine, plasma and CSF of the patient 
were elevated 80-fold and 20-fold respectively compared to the control means. 
Aspartoacylase activity was absent in the patient's fibroblasts. 
Table 2 shows the NAA concentrations in amniotic fluid of controls and the 
pregnancy at risk, together with the enzymatic data in amniotic fluid cells. NAA 
levels in the control amniotic fluid samples are accurately measurable; the level in 
the pregnancy at risk was found to be in the control range. Aspartoacylase activity 
in amniotic fluid cells was considerably lower than in cultured skin fibrobtasts. In 
some controls the activity in amniocytes approached the lower limit of reliable 
determinations; this was also the case for the cells from the pregnancy at risk. 
DISCUSSION 
In the isotope dilution assay the [D3]-NAA serves as a carrier as well as the ideal 
internal standard for quantitation. It protects against the loss of small amounts of 
endogenous NAA during the entire procedure. 
The chemical ionization technique increased the sensitivity and therefore the stable 
isotope dilution GC-MS CI mass fragmentographic detection allows highly sensitive, 
specific and accurate measurements. Although NAA recovery in the solvent extraction 
procedure is low and variable, the introduction of the labelled internal standard 
circumvents this problem. 
Table 2 Concentrations of N-acetylaspartic acid in amniotic fluid and aspartoacylase 
activity in amniotic fluid cells of the pregnancy at risk and controls 
N-acetylaspartic acid in 
amniotic fluid 
(#tool/L) 
Aspartoacylase in
amniotic fluid cells 
(nmol h- 1 (mg protein)- 1) 
At-risk pregnancy 1.82 0.29 
Controls (n = 10) 
mean 1.27 -t- 0.74 1.3 -t- 1.1 
range 0.30-2.55 0.32-3.4 
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This method has enabled us to establish reference ranges of NAA concentrations 
in CSF, plasma, urine and amniotic fluid. NAA appears to be a normal constituent 
in the body fluids rather than a unique metabolite restricted to pathological states. 
Therefore the distinction between normal and pathological states requires quantitative 
assessment of NAA levels. Although synthesis of NAA has not been reported in any 
organ other than the central nervous system (Kvittingen et al., 1986), very low 
concentrations are normally found in CSF and plasma. The high concentration of
NAA in neurons is probably very efficiently kept within the cells (Kvittingen et al., 
1986; Hagenfeldt et al., 1987). 
The high level of NAA in CSF of patients and the concentration gradient from 
CSF to plasma indicates that indeed the brain is the source of NAA. The high levels 
in urine must be due to efficient excretion by glomerular filtration. 
In accordance with the previous reports on Canavan disease we found in the 
present patient greatly elevated concentrations of NAA in urine and plasma and a 
clear deficiency of aspartoacylase activity in skin fibroblasts. This confirmed the 
feasibility of biochemical diagnosis of Canavan disease and suggested the use 
of similar methods for prenatal diagnosis. However, in amniotic fluid cells the 
aspartoacylase activity appeared to be considerably lower than in skin fibroblasts, 
which severely hampers the accuracy of measurements at the lower limit of the range. 
The low aspartoacylase activity in the investigated at-risk pregnancy did not, 
therefore, allow a definite diagnosis. Further studies of amniotic fluid cells and 
chorionic villi and improvement of the enzyme assay will be needed to provide 
reliable prenatal diagnosis by this approach in all cases. 
The NAA level detected by GC-MS with SIM in amniotic fluid from the pregnancy 
at risk was within the normal range, which suggested an unaffected fetus; the 
pregnancy was continued and the now 1-year-old child is healthy. 
It remains to be established whether the NAA level in an affected pregnancy at 16 
weeks is indeed increased. The present sensitive stable isotope dilution method should 
detect any significant elevation in amniotic fluid even if this would be far less than 
in urine of patients with Canavan disease. 
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